News|Articles|February 13, 2019

Daurismo for Newly Diagnosed AML

Author(s)Drew Boxler

Daurismo (glasdegib, Pfizer)

Indications: Newly-diagnosed acute myeloid leukemia (AML) in adult patients who are 75 years old or older and have comorbidities that preclude use of intensive induction chemotherapy

Dosage: 100 mg orally, once daily.

Contraindications: None

Click here for more prescribing information

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


Latest CME